Some Boston-area researchers said the decision by advisors to the U.S. Food and Drug Administration reflected challenges facing regulators as psychedelic treatments enter mainstream psychiatry.
Psychedelic-assisted therapy is poised to move from the research setting to clinical practice, and a group of experts offer seven essential elements of informed consent for psychedelic therapy.
Q&A: Why regulators may toss cold water on buzz over psychedelics medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.